RT Journal Article
T1 Advances in Transversal Topics Applicable to the Care of Bladder Cancer Patients in the Real-World Setting.
A1 Garrido Siles, Marga
A1 López-Beltran, Antonio
A1 Pelechano, Paula
A1 García Vicente, Ana María
A1 Gironés Sarrió, Regina
A1 González-Haba Peña, Eva
A1 Rodríguez Antolín, Alfredo
A1 Zapatero, Almudena
A1 Arranz, José Ángel
A1 Climent, Miguel Ángel
A1 Spanish Oncology Genitourinary Multidisciplinary Working Group, 
K1 bladder cancer
K1 imaging techniques
K1 immune checkpoints inhibitors
K1 liquid biopsy
K1 safety drug administration
AB Recommendations regarding transversal topics applicable to bladder cancer patients independent of tumor grade and stage were established by members of the Spanish Oncology Genitourinary Multidisciplinary Working Group (SOGUG). Liquid biopsy in urine and blood samples is useful in the surveillance of non-muscle-invasive and muscle-invasive bladder cancer, respectively. Multiparametric MRI is an accurate, faster and non-invasive staging method overcoming the understaging risk of other procedures. The combination of FDG-PET/MRI could improve diagnostic reliability, but definite criteria for imaging interpretation are still unclear. Hospital oncology pharmacists as members of tumor committees improve the safety of drug use. Additionally, safety recommendations during BCG preparation should be strictly followed. The initial evaluation of patients with bladder cancer should include a multidimensional geriatric assessment. Orthotopic neobladder reconstruction should be offered to motivated patients with full information of self-care requirements. Bladder-sparing protocols, including chemoradiation therapy and immune checkpoints inhibitors (ICIs), should be implemented in centers with well-coordinated multidisciplinary teams and offered to selected patients. The optimal strategy of treatment with ICIs should be defined from the initial diagnostic phase with indications based on scientific evidence. Centralized protocols combined with the experience of professional groups are needed for the integral care of bladder cancer patients.
SN 2072-6694
YR 2022
FD 2022-08-17
LK http://hdl.handle.net/10668/20913
UL http://hdl.handle.net/10668/20913
LA en
DS RISalud
RD Apr 7, 2025